Übersichtsarbeit
Uwe Wollina
Dermatosen der Zunge – eine Übersicht
Dermatoses of the tongue – a review
Keywords | Summary | Correspondence | Literature
Keywords
hereditary diseases, inflammation, skin diseases, Tongue, vasculitis
Schlüsselworte
Dermatosen, Entzündung, Genodermatosen, Vaskulitis, Zunge
Summary
Dermatoses of the tongue are a challenge for clinical diagnostics, since a variety of different disorders may present with similar lesions. In this review we will focus on non-neoplastic, non-infectious disorders. Chronic inflammatory skin diseases, vasculitis, neuro-cutaneous dermatoses, hereditary diseases, and autoimmmune disorders are discussed.
Zusammenfassung
Dermatosen der Zunge stellen den Untersucher vor besondere Herausforderungen, da die klinischen Bilder verschiedener Erkrankungen sich ähneln können. In der vorliegenden Übersicht liegt der Schwerpunkt auf nicht-tumorösen, nicht-infektiösen Erkrankungen. Im Einzelnen werden chronisch-entzündliche Dermatosen, Vaskulitiden, neurokutane Dermatosen, Genodermatosen und Autoimmunerkrankungen.
Leider haben Sie sich nicht eingeloggt, um den Beitrag lesen zu können. Bitte loggen Sie sich ein oder beantragen Sie Ihre Zugangsberechtigung. Vielen Dank. Weitere Informationen finden Sie hier>
Korrespondenz-Adresse
Prof.Dr.med. Uwe Wollina
Klinik für Dermatologie und Allergologie
Städtisches Klinikum Dresden
Friedrichstr. 41
DE-01067 Dresden
Email: uwe.wollina@klinikum-dresden.de
Conflict of Interests
Der Autor erhielt keine spezielle Finanzierung für diese Arbeit und gibt an, dass kein Interessenkonflikt besteht.
Literatur
1. Alrashdan MS, Cirillo N, McCullough M (2016): Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308(8):539-51.
2. Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES, Gandolfo S. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol. 2004;122(1):87-94.
3. Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020;2(2):CD001168.
4. Lier GC, Mrowietz U, Wolfart M, Warnke PH, Wiltfang J, Springer IN. Psoriasis of the tongue. J Craniomaxillofac Surg. 2009;37(1):51-3.
5. Shareef S, Ettefagh L. Geographic tongue. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
6. Damiani G, Gironi LC, Pacifico A, Pigatto PDM, Malagoli P, Bindi M, Francetti L, Maiorana C, Poli P, Taschieri S, Corbella S, Del Fabbro M, Marino S, Spadari F, Savoia P. Cutaneous and oral comorbidities in patients with geographic tongue: a multicenter multidisciplinary cross-sectional observational study. J Biol Regul Homeost Agents. 2021;35(2 Suppl. 1):339-44.
7. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84(5):269-76.
8. Sobrinho RABS, de Lima KCA, Moura HC, Araújo MM, de Assis CMRB, Gouveia PADC. Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review. Case Rep Med. 2017;2017:6327437.
9. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990 Aug;33(8):1122-8.
10. Prieto-Peña D, Castañeda S, Atienza-Mateo B, Blanco R, González-Gay MÁ. A Review of the Dermatological Complications of Giant Cell Arteritis. Clin Cosmet Investig Dermatol. 2021;14:303-12.
11. Baykal Selçuk L, Ferhatosmanoğlu A, Gayretli Aydın ZG, Aksu Arıca D, Yeşilbaş O. Dermatologic manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic. An Bras Dermatol. 2023;98(2):168-75.
12. Klein B, Thoppay JR, De Rossi SS, Ciarrocca K. Burning Mouth Syndrome. Dermatol Clin. 2020;38(4):477-83.
13. Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(3):373-7.
14. Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: a systematic review of treatments. Oral Dis. 2018;24(3):325-34.
15. Gonçalves DU, de Castro MM, Galvão CP, Brandão AZ, de Castro MC, Lambertucci JR. Cheilitis granulomatosa associated with Melkersson-Rosenthal syndrome. Braz J Otorhinolaryngol. 2007;73(1):132-3.
16. Bacci C, Valente ML. Successful treatment of cheilitis granulomatosa with intralesional injection of triamcinolone. J Eur Acad Dermatol Venereol. 2010;24(3):363-4.
17. Horev L, Wollina U, Potikha T, Hafner A, Ingber A, Liu L, McGrath JA, Zlotogorski A. Lipoid proteinosis: identification of two novel mutations in the human ECM-1 gene and lack of genotype-phenotype correlation. Acta Derm Venereol. 2009;89(5):528-9.
18. Wollina U, Konrad H, Schönlebe J. Lipoid proteinosis. Acta Dermatovenerol Alp Pannonica Adriat. 2004;13(4):131-4.
19. Kucuk U, Erdogan IG, Bayol U, Hacioglu N, Cukurova I, Bicakci C. Urbach-Wiethe disease (lipoid proteinosis). Indian J Pathol Microbiol. 2012;55(3):375-6.
20. Dupuis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost. 2010;8(7):1447-56.
21. Fuchizaki U, Miyamori H, Kitagawa S, Kaneko S, Kobayashi K. Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Lancet. 2003;362(9394):1490-4.
22. Hyldahl SJ, El-Jaji MQ, Schuster A, Kjeldsen AD. Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients. Int J Dermatol. 2022;61(12):1497-1505.
23. Abiri A, Goshtasbi K, Maducdoc M, Sahyouni R, Wang MB, Kuan EC. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review. Lasers Surg Med. 2020;52(4):293-300.
24. Kritharis A, Al-Samkari H, Kuter DJ. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective. Haematologica. 2018;103(9):1433-43.
25. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338-47.
26. Kudsi M, Khalayli N, Allahham A. Behcet's disease: Diagnosed as isolated recurrent oral aphthae; a case report. Ann Med Surg (Lond). 2022;81:104327.
27. Messersmith L, Krauland K. Pemphigus vegetans. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
28. Verma GK, Tegta GR, Sharma A, Kaur M, Sharma S. A Rare Case of Extensive Pemphigus Vegetans. Indian Dermatol Online J. 2019;11(1):87-90.
29. Ellebrecht CT, Payne AS. Setting the target for pemphigus vulgaris therapy. JCI Insight. 2017;2(5):e92021.
30. Ingold CJ, Khan MAB. Pemphigus vulgaris. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
31. Nguyen T, Ahmed AR. Pemphigus vulgaris localized to the tongue. J Dermatol Case Rep. 2014;8(2):55-7.
32. Cichońska D, Komandera D, Mazuś M, Kusiak A. Chronic Ulcerative Stomatitis (CUS) as an Interdisciplinary Diagnostic Challenge: A Literature Review. Int J Mol Sci. 2022;23(22):13772.
33. Wörle B, Wollenberg A, Schaller M, Kunzelmann KH, Plewig G, Meurer M. Chronic ulcerative stomatitis. Br J Dermatol. 1997;137(2):262-5.
34. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685-99.
35. Benz K, Baulig C, Knippschild S, Strietzel FP, Hunzelmann N, Jackowski J. Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma - A Systematic Review. Int J Environ Res Public Health. 2021;18(10):5238.
36. Wollina U, Verma SB, Ali FM, Patil K. Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol. 2015;8:193-204.
37. Ali FM, Wollina U, Raj APN, Japati S. Prevalence of unilateral oral submucous fibrosis: an evidence-based study. J Head Neck Physicians & Surgeons. 2015;8(1):58-63.
38. Qin X, Ning Y, Zhou L, Zhu Y. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets. Int J Mol Sci. 2023;24(5):4992.
